Study of Osteopontin as the “CA125” Adjunct for Detection of Ovarian Carcinoma in Patients with Pelvic Mass
Reports of Radiotherapy and Oncology: September 01, 2013, 1 (2); 59-64
September 01, 2013
- Article Type: Research Article
June 08, 2013
July 28, 2013
S. Study of Osteopontin as the “CA125” Adjunct for Detection of Ovarian Carcinoma in Patients with Pelvic Mass,
Rep Radiother Oncol.
© 0, Reports of Radiotherapy and Oncology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
References are available in the PDF.